Tarsus Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Tarsus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Tarsus Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Tarsus Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $6.2M | 104k | 59.43 |
| 2025-06-30 | $2.5M | 61k | 40.51 |
| 2024-09-30 | $1.5M | 47k | 32.89 |
| 2024-06-30 | $2.3M | 85k | 27.18 |
| 2024-03-31 | $3.5M | 97k | 36.35 |
| 2023-12-31 | $1.8M | 90k | 20.25 |
| 2023-09-30 | $723k | 41k | 17.77 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management